menu
    • menu

    Company profile for Loxo Oncology Inc

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    At Loxo Oncology, we are focused on developing treatments for people with cancers that are caused by a single inappropriate DNA change, known as an “oncogenic driver.” Our work focuses on these single gene abnormalities, such that one medicine could have the potential to treat the cancer with dramatic effect. To the greatest extent possible, we are working to design highly selective medicines because we believe drugs built...
    At Loxo Oncology, we are focused on developing treatments for people with cancers that are caused by a single inappropriate DNA change, known as an “oncogenic driver.” Our work focuses on these single gene abnormalities, such that one medicine could have the potential to treat the cancer with dramatic effect. To the greatest extent possible, we are working to design highly selective medicines because we believe drugs built with a single purpose have the highest probability of deeply inhibiting the affected pathway.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Loxo Oncology IncUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    281 Tresser Blvd, 9th Floor Stamford, CT 06901
    Telephone
    Telephone
    +1 203.653.3880
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.loxooncology.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/loxo-oncology-inc-/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/loxooncology?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eli Lilly's Jaypirca gets US nod for mantle cell lymphoma
    Eli Lilly's Jaypirca gets US nod for mantle cell lymphoma

    28 Jan 2023

    // Kyle LaHucik ENDPTS

    https://endpts.com/lilly-enters-ripe-btk-field-with-quick-fda-nod-in-mantle-cell-lymphoma/

    Kyle LaHucik ENDPTS
    28 Jan 2023
    Share Share
    Lilly’s Loxo rounds out the PhI/II data for lymphoma drug under FDA review
    Lilly’s Loxo rounds out the PhI/II data for lymphoma drug under FDA review

    12 Dec 2022

    // ENDPTS

    https://endpts.com/ash22-lillys-loxo-rounds-out-the-phi-ii-data-for-lymphoma-drug-under-fda-review/

    ENDPTS
    12 Dec 2022
    Share Share
    Lilly, Foghorn Collaborate for Novel Oncology Targets Using Gene Traffic Control
    Lilly, Foghorn Collaborate for Novel Oncology Targets Using Gene Traffic Control

    13 Dec 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-and-foghorn-announce-strategic-collaboration-for-novel-oncology-targets-using-foghorns-proprietary-gene-traffic-control-platform-301442627.html

    PRNEWSWIRE
    13 Dec 2021
    Share Share
    Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC
    Loxo Oncology at Lilly Announces Details of Presentations at 2021 AACR-NCI-EORTC

    07 Oct 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/loxo-oncology-at-lilly-announces-details-of-presentations-at-2021-aacr-nci-eortc-virtual-international-conference-on-molecular-targets-and-cancer-therapeutics-301394505.html

    PRNEWSWIRE
    07 Oct 2021
    Share Share
    Lilly and Kumquat Biosciences Discover and Develop Novel Small Molecules
    Lilly and Kumquat Biosciences Discover and Develop Novel Small Molecules

    29 Jul 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/lilly-and-kumquat-biosciences-announce-collaboration-to-discover-and-develop-novel-small-molecules-that-stimulate-tumor-specific-immune-responses-301343650.html

    PRNEWSWIRE
    29 Jul 2021
    Share Share
    Loxo Oncology at Lilly Announces Publication of Pirtobrutinib (LOXO-305)
    Loxo Oncology at Lilly Announces Publication of Pirtobrutinib (LOXO-305)

    05 Mar 2021

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/loxo-oncology-at-lilly-announces-publication-of-pirtobrutinib-loxo-305-phase-12-data-in-the-lancet-301241157.html

    PRNEWSWIRE
    05 Mar 2021
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search